TNF and Hepatic steatosis: Metformin acting as the first-line hypoglycemic drug improves hepatic insulin resistance mainly by decreasing hepatic expression of TNF-α, a cytokine that promotes insulin resistance [25, 27, 41], ameliorates hepatic steatosis and decreases aminotransferase levels, thus causes reversal of fatty liver [27, 41].